Skip to main content

Stereotaxis, Inc.

STXS
Exchange
NYSE
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001289340

No open-market purchases or sales by Stereotaxis, Inc. insiders were filed in the last 90 days; 108 institutions reported holding it in 13F filings for Q2 2026, worth $74.1M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Stereotaxis, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of STXS: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders84286+4
Shares40.5M44.4K41.2M+828.1K (+2.0%)
Value$82.5M$90.5K$94.0M+$11.6M (+14.1%)

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (12)

Institutions that held Stereotaxis, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to STXS in Q4 2024
InstitutionSharesValue% of portfolio
Traynor Capital Management, Inc.160,509$366.0K0.03%
Diametric Capital, LP95,161$217.0K0.15%
Raymond James Financial Inc44,350$101.1K0.00%
Prelude Capital Management, LLC32,170$73.3K0.01%
Intech Investment Management LLC25,318$57.7K0.00%
Two Sigma Securities, LLC23,847$54.4K0.01%
Police & Firemen's Retirement System of New Jersey17,997$41.0K0.00%
BNP Paribas Arbitrage, SA8,583$19.6K0.00%
Signaturefd, LLC1,000$2.28K0.00%
SBI Securities Co., Ltd.334$7620.00%
Compass Planning Associates Inc244$5560.00%
Clark Wealth Partners100$2280.00%

Sold out (8)

Institutions that held Stereotaxis, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of STXS in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Cerity Partners LLC124,011$253.0K
Jane Street Group, LLC29,773$60.7K
ExodusPoint Capital Management, LP21,538$44.0K
Acadian Asset Management LLC8,852$18.0K
Simplex Trading, LLC1,184$2.00K
Russell Investments Group, Ltd.450$918
Aspire Private Capital, LLC200$408
Capital Performance Advisors LLP43$88

Not filed for Q4 2024 yet (2)

Institutions that held Stereotaxis, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding STXS in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Raymond James Financial Services Advisors, Inc.34,000$69.4K
Raymond James & Associates10,350$21.1K